Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 5
2015 6
2016 1
2017 1
2018 2
2019 1
2020 7
2021 17
2022 8
2023 10
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Potential Mechanisms of Cancer-Related Hypercoagulability.
Nasser NJ, Fox J, Agbarya A. Nasser NJ, et al. Among authors: agbarya a. Cancers (Basel). 2020 Feb 29;12(3):566. doi: 10.3390/cancers12030566. Cancers (Basel). 2020. PMID: 32121387 Free PMC article. Review.
Overcoming Chemoresistance in Cancer: The Promise of Crizotinib.
Musa S, Amara N, Selawi A, Wang J, Marchini C, Agbarya A, Mahajna J. Musa S, et al. Among authors: agbarya a. Cancers (Basel). 2024 Jul 7;16(13):2479. doi: 10.3390/cancers16132479. Cancers (Basel). 2024. PMID: 39001541 Free PMC article. Review.
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer.
Christopoulos P, Harel M, McGregor K, Brody Y, Puzanov I, Bar J, Elon Y, Sela I, Yellin B, Lahav C, Raveh S, Reiner-Benaim A, Reinmuth N, Nechushtan H, Farrugia D, Bustinza-Linares E, Lou Y, Leibowitz R, Kamer I, Zer Kuch A, Moskovitz M, Levy-Barda A, Koch I, Lotem M, Katzenelson R, Agbarya A, Price G, Cheley H, Abu-Amna M, Geldart T, Gottfried M, Tepper E, Polychronis A, Wolf I, Dicker AP, Carbone DP, Gandara DR. Christopoulos P, et al. Among authors: agbarya a. JCO Precis Oncol. 2024 Mar;8:e2300555. doi: 10.1200/PO.23.00555. JCO Precis Oncol. 2024. PMID: 38513170 Free PMC article.
First line Immunotherapy for Non-Small Cell Lung Cancer.
Nasser NJ, Gorenberg M, Agbarya A. Nasser NJ, et al. Among authors: agbarya a. Pharmaceuticals (Basel). 2020 Nov 8;13(11):373. doi: 10.3390/ph13110373. Pharmaceuticals (Basel). 2020. PMID: 33171686 Free PMC article. Review.
Treatment of Rare Mutations in Patients with Lung Cancer.
Taha T, Khoury R, Brenner R, Nasrallah H, Shofaniyeh I, Yousef S, Agbarya A. Taha T, et al. Among authors: agbarya a. Biomedicines. 2021 May 11;9(5):534. doi: 10.3390/biomedicines9050534. Biomedicines. 2021. PMID: 34064757 Free PMC article. Review.
Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry.
Mountzios G, Planchard D, Metro G, Tsiouda D, Prelaj A, Lampaki S, Shalata W, Riudavets M, Christopoulos P, Girard N, Albarrán-Artahona V, Garcia Campelo R, Samitas K, Banna GL, Boukovinas I, Agbarya A, Koumarianou A, Perdikouri EI, Kosmidis P, Linardou H, Mauri D, Mavroudis D, Athanasiadis I, Kalofonos H, Xenidis N, Korantzis I, Ardavanis A, Rallis G, Bottiglieri A, Efthymiadis K, Oikonomopoulos G, Kokkalis A, Saloustros E, Tsoukalas N, Bartzi D, Economopoulou P, Psyrri A, Reck M, Lo Russo G. Mountzios G, et al. Among authors: agbarya a. JTO Clin Res Rep. 2022 Nov 20;4(1):100433. doi: 10.1016/j.jtocrr.2022.100433. eCollection 2023 Jan. JTO Clin Res Rep. 2022. PMID: 36793384 Free PMC article.
64 results